Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Cerilliant
Merck
Deloitte
Harvard Business School
Boehringer Ingelheim
Moodys
Mallinckrodt

Generated: January 19, 2019

DrugPatentWatch Database Preview

EFAVIRENZ Drug Profile

« Back to Dashboard

When do Efavirenz patents expire, and when can generic versions of Efavirenz launch?

Efavirenz is a drug marketed by Aurobindo Pharma Ltd, Cipla, Hetero Labs Ltd Iii, Mylan Pharms Inc, Strides Pharma, and Teva Pharms Usa. and is included in ten NDAs.

The generic ingredient in EFAVIRENZ is efavirenz; lamivudine; tenofovir disoproxil fumarate. There are twenty-six drug master file entries for this compound. One supplier is listed for this compound. There are twenty-eight tentative approvals for this compound. Additional details are available on the efavirenz; lamivudine; tenofovir disoproxil fumarate profile page.

US Patents and Regulatory Information for EFAVIRENZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd EFAVIRENZ efavirenz CAPSULE;ORAL 078064-001 Dec 15, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hetero Labs Ltd Iii EFAVIRENZ efavirenz TABLET;ORAL 078886-001 Apr 27, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd EFAVIRENZ efavirenz TABLET;ORAL 077673-001 Sep 21, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE efavirenz; lamivudine; tenofovir disoproxil fumarate TABLET;ORAL 022343-001 Aug 15, 2018 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKesson
Cerilliant
Cipla
Deloitte
Healthtrust
Moodys
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.